GO
Loading...

Amgen Names Bradway to Replace Nanula as Chief Financial Officer

Reuters
Tuesday, 10 Apr 2007 | 4:55 PM ET

Amgen, theworld's largest biotechnology company, said after U.S. markets closed Tuesday that it appointed Robert Bradway as chief financial officer.

Bradway replaces Richard Nanula, who is leaving the company to pursue other opportunities.

Bradway, 44, joined Amgen in 2006 as vice president, operations strategy. Prior to joining Amgen, he spent 18 years at Morgan Stanley.

Nanula will remain at Amgen for the next 90 days to assist in the transition.

  Price   Change %Change
AMGN
---

Featured

Contact U.S. News

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    › Learn More

Don't Miss

U.S. Video